
Chelone Aesthetics and Wellness Center operates in La Grange, Kentucky, providing medically supervised weight loss programs centered on GLP-1 receptor agonist therapy. The clinic focuses exclusively on semaglutide-based weight management protocols, delivering structured treatment plans that combine pharmacological intervention with metabolic monitoring. Located in Oldham County, the practice serves patients throughout the Louisville metropolitan area and surrounding Kentucky communities seeking evidence-based approaches to obesity and weight-related metabolic dysfunction.
The clinic's semaglutide programs follow FDA-approved dosing protocols for chronic weight management in adults with BMI ≥30 or BMI ≥27 with at least one weight-related comorbidity. Treatment begins with comprehensive metabolic assessment including body composition analysis, fasting glucose evaluation, and cardiovascular risk stratification. Patients receive weekly subcutaneous semaglutide injections with dose titration over 16-20 weeks, reaching maintenance levels between 1.7mg and 2.4mg based on individual tolerance and response. The clinic provides all injection supplies, refrigerated medication storage guidance, and detailed administration training during initial consultations. Monthly follow-up appointments track weight trajectory, assess side effect profiles, and adjust nutritional recommendations as gastric emptying changes affect satiety patterns.
Chelone Aesthetics and Wellness Center's medical team includes licensed providers trained in obesity medicine and metabolic therapeutics who oversee all semaglutide prescribing and monitoring. Each patient undergoes baseline laboratory work including comprehensive metabolic panel, lipid profile, hemoglobin A1c, and thyroid function tests before treatment initiation. The clinic excludes candidates with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease. Providers conduct medication reconciliation to identify potential drug interactions, particularly with insulin, sulfonylureas, and medications requiring specific gastric pH for absorption. Patients with type 2 diabetes receive modified protocols with closer glucose monitoring during the initial titration phase.
The treatment experience at Chelone Aesthetics and Wellness Center includes structured nutritional counseling that addresses the reduced caloric intake typical during semaglutide therapy, emphasizing protein preservation to minimize lean muscle loss during weight reduction. The clinic provides meal timing strategies to manage common gastrointestinal effects including nausea, constipation, and early satiety. Patients receive written protocols for managing potential adverse events and 24-hour access to clinical staff for urgent concerns. The La Grange location offers flexible appointment scheduling including early morning and evening slots to accommodate working patients. Treatment duration typically extends 12-18 months, with some patients transitioning to maintenance dosing for long-term weight stability.
Chelone Aesthetics and Wellness Center distinguishes itself through transparent pricing structures for semaglutide programs, with costs clearly outlined before treatment initiation. The clinic maintains relationships with compounding pharmacies and manufacturer savings programs to improve medication accessibility for patients without insurance coverage for weight management. All consultations occur in-person at the La Grange facility, allowing for direct body composition measurements and face-to-face clinical assessment. The practice does not offer telehealth services, maintaining that in-person monitoring provides superior safety oversight for GLP-1 therapy. Patients commit to minimum monthly check-ins throughout active weight loss phases, with visit frequency determined by individual metabolic response and the presence of comorbid conditions requiring concurrent management.
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.